Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of inhaled laninamivir octanoate TwinCaps in adults with symptomatic influenza A or B
2013-000582-36Phase 2Terminated
- Sponsor
- Biota Scientific Management
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of laninamivir octanoate in influenza, Influenza A infection and influenza B (3 arms), sponsored by Biota Scientific Management. Primary endpoint: Time to alleviation of influenza symptoms and fever. Started Aug 2013; status: terminated.
02
Drugs
laninamivir octanoate
03
Conditions
influenzaInfluenza A infectioninfluenza B
Beyond the preview
Go deeper on 2013-000582-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000582-36.